title: [Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines].
abstract: The treatment of attention deficit hyperactivity disorders (ADHD) requires extensive diagnosis. Check lists and questionnaires may be helpful. Comorbidities are common and must be clarified. ADHD should be treated over a longer period of time. A multimodal treatment concept is recommended in which the administration of psychostimulants is combined with educational and behavioural therapeutic measures.
authors.affiliation: Klinik und Poliklinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters der Universität zu Köln. gerd.lehmkuhl@uk-koeln.de
authors.forename: G
authors.initials: G
authors.lastname: Lehmkuhl
mesh_terms: D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000662:Amphetamines / Q000008:administration & dosage / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D006801:Humans; D017410:Practice Guidelines as Topic; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000662:Amphetamines; D000697:Central Nervous System Stimulants; D011437:Propylamines; D011619:Psychotropic Drugs; D000069445:Atomoxetine Hydrochloride